{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:22:16Z","timestamp":1792120936479,"version":"4.4.0"},"reference-count":12,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,30]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The level of frailty, according to the International Myeloma Working Group frailty index, is highly dynamic during antimyeloma treatment. Dynamic frailty assessment improved the prediction of survival and early mortality compared with the prognostic value of static frailty level at baseline.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024025868","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T21:11:01Z","timestamp":1732309861000},"page":"543-546","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma"],"prefix":"10.1182","volume":"145","author":[{"given":"Febe","family":"Smits","sequence":"first","affiliation":[{"name":"1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"2Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"},{"name":"3Department of Hematology, Haga Hospital, The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaz","family":"Groen","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"2Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-3547","authenticated-orcid":false,"given":"Mark-David","family":"Levin","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A. M.","family":"Stege","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"van Kampen","sequence":"additional","affiliation":[{"name":"6Department of Internal Medicine, Zuyderland Hospital, Sittard, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van der Spek","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz M.","family":"Bilgin","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine, Ardz Hospital, Goes, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje","family":"Thielen","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Nijhof","sequence":"additional","affiliation":[{"name":"10Department of Internal Medicine, Antonius Hospital, Nieuwegein, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Ludwig","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Bernhoven Hospital, Uden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G. M.","family":"de Waal","sequence":"additional","affiliation":[{"name":"12Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8716-0856","authenticated-orcid":false,"given":"Yorick","family":"Sandberg","sequence":"additional","affiliation":[{"name":"13Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-867X","authenticated-orcid":false,"given":"Alain","family":"Kentos","sequence":"additional","affiliation":[{"name":"14Department of Hematology, Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan","family":"Timmers","sequence":"additional","affiliation":[{"name":"15Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josien C.","family":"Regelink","sequence":"additional","affiliation":[{"name":"16Department of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Westerman","sequence":"additional","affiliation":[{"name":"17Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"de Heer","sequence":"additional","affiliation":[{"name":"18Department of Internal Medicine, Flevoziekenhuis, Almere, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christiane","family":"Vekemans","sequence":"additional","affiliation":[{"name":"19Department of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazik","family":"Durdu-Rayman","sequence":"additional","affiliation":[{"name":"20Department of Internal Medicine, Franciscus Hospital, Schiedam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-0856","authenticated-orcid":false,"given":"Nicole C. H. P.","family":"de Graauw","sequence":"additional","affiliation":[{"name":"21Department of Internal Medicine, Bravis Hospital, Roosendaal, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-0354","authenticated-orcid":false,"given":"Maarten R.","family":"Seefat","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"2Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels W. C. J.","family":"van de Donk","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"2Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula F.","family":"Ypma","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Haga Hospital, The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Nasserinejad","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5011-1820","authenticated-orcid":false,"given":"Sonja","family":"Zweegman","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"2Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"13","key":"2025013016202614400_bib1","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2025013016202614400_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41408-022-00779-2","article-title":"The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic review","volume":"13","author":"Mian","year":"2023","journal-title":"Blood Cancer J"},{"issue":"6","key":"2025013016202614400_bib3","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3324\/haematol.2021.280424","article-title":"Improved survival in myeloma patients\u2013a nationwide registry study of 4,647 patients &gt;75 years treated in Denmark and Sweden","volume":"108","author":"Moore","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"2025013016202614400_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-023-00843-5","article-title":"Dynamic frailty risk assessment among older adults with multiple myeloma: a population-based cohort study","volume":"13","author":"Mian","year":"2023","journal-title":"Blood Cancer J"},{"issue":"1","key":"2025013016202614400_bib5","doi-asserted-by":"crossref","first-page":"afab211","DOI":"10.1093\/ageing\/afab211","article-title":"Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study","volume":"51","author":"Yao","year":"2022","journal-title":"Age Ageing"},{"issue":"18","key":"2025013016202614400_bib6","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1002\/cncr.33658","article-title":"Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort","volume":"127","author":"Scheubeck","year":"2021","journal-title":"Cancer"},{"issue":"25","key":"2025013016202614400_bib7","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.20.03143","article-title":"Ixazomib, daratumumab, and low-dose dexamethasone in frail patients with newly diagnosed multiple myeloma: the Hovon 143 study","volume":"39","author":"Stege","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"2025013016202614400_bib8","doi-asserted-by":"crossref","first-page":"102167","DOI":"10.1016\/j.eclinm.2023.102167","article-title":"Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial","volume":"63","author":"Groen","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"2025013016202614400_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1541-0420.2010.01546.x","article-title":"Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data","volume":"67","author":"Rizopoulos","year":"2011","journal-title":"Biometrics"},{"issue":"22","key":"2025013016202614400_bib10","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1182\/blood.V128.22.3305.3305","article-title":"Feasibility and efficacy of dose adjusted melphalan-prednisone-bortezomib (MPV) in elderly patients \u2265 75 years of age with newly diagnosed multiple myeloma; the non-randomised phase II HOVON 123 study [abstract]","volume":"128","author":"Zweegman","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2025013016202614400_bib11","doi-asserted-by":"crossref","first-page":"e056147","DOI":"10.1136\/bmjopen-2021-056147","article-title":"Frailty-adjusted therapy in transplant non-eligible patients with newly diagnosed multiple myeloma (FiTNEss (UK-MRA Myeloma XIV trial)): a study protocol for a randomised phase III trial","volume":"12","author":"Coulson","year":"2022","journal-title":"BMJ Open"},{"issue":"suppl 1","key":"2025013016202614400_bib12","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1182\/blood-2023-188672","article-title":"Dynamic frailty assessment in transplant non-eligible newly diagnosed myeloma patients: initial data from UK Myeloma Research Alliance (UK-MRA) Myeloma XIV (FiTNEss): a frailty-adjusted therapy study [abstract]","volume":"142","author":"Cook","year":"2023","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/5\/543\/2353496\/blood_bld-2024-025868-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/5\/543\/2353496\/blood_bld-2024-025868-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:20:37Z","timestamp":1738254037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/5\/543\/526135\/Beyond-static-measurements-dynamic-frailty"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,1,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024025868","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]}}}